What are Recombinant subunit vaccine drugs?

Recombinant subunit vaccine drugs are pharmacologic agents that share a common mechanism (typically targeting Prefusion form of the RSV F protein). 4 are currently marketed, with 3 more in clinical development.

What are the marketed Recombinant subunit vaccine drugs?

Marketed Recombinant subunit vaccine drugs include RSVpreF 120 µg, Zoster Vaccine Recombinant, recombinant subunit Herpes zoster vaccine, RZV.

Recombinant subunit vaccine

4 marketed 3 in Phase 3

This page covers all Recombinant subunit vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Prefusion form of the RSV F protein, Varicella-zoster virus glycoprotein E (gE), Varicella-zoster virus glycoprotein E (VZV gE).

Targets

Prefusion form of the RSV F protein · Varicella-zoster virus glycoprotein E (gE) · Varicella-zoster virus glycoprotein E (VZV gE)

Marketed (4)

RSVpreF 120 µg · Pfizer · Immunology
Zoster Vaccine Recombinant · University of Colorado, Denver · Immunology / Infectious Disease
This recombinant zoster vaccine stimulates the immune system to prevent herpes zoster (shingles) by inducing varicella-zoster virus (VZV)-specific cell-mediated and humoral immunity.
recombinant subunit Herpes zoster vaccine · University Health Network, Toronto · Immunology / Infectious Disease
A recombinant subunit vaccine that stimulates the immune system to recognize and prevent herpes zoster (shingles) infection by presenting viral antigens without live virus.
RZV · GlaxoSmithKline · Immunology / Infectious Disease
RZV is a recombinant zoster vaccine that stimulates the immune system to prevent herpes zoster (shingles) infection.

Phase 3 pipeline (3)

Herpes Zoster vaccine GSK1437173A · GlaxoSmithKline · Immunology / Infectious Disease
This vaccine stimulates the immune system to recognize and attack varicella-zoster virus (VZV) to prevent herpes zoster (shingles) infection.
PROVARIX · Sinovac (Dalian) Vaccine Technology Co., Ltd. · Immunology / Infectious Disease
PROVARIX is a recombinant varicella-zoster virus (VZV) vaccine designed to prevent herpes zoster (shingles) and post-herpetic neuralgia in immunocompetent and immunocompromised populations.
HZ/su vaccine GSK1437173A · GlaxoSmithKline · Immunology / Infectious Disease
This recombinant zoster vaccine stimulates immune responses against varicella-zoster virus (VZV) to prevent herpes zoster (shingles) and post-herpetic neuralgia in older adults.